Arrowhead Pharmaceuticals
ARWR
#2055
Rank
NZ$16.07 B
Marketcap
NZ$114.82
Share price
0.30%
Change (1 day)
226.05%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): NZ-$1.89

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$2.07. In 2024 the company made an earnings per share (EPS) of NZ-$8.28 a decrease over its 2023 EPS that were of NZ-$3.17.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.89-77.14%
2024NZ-$8.28161.39%
2023NZ-$3.1717.36%
2022NZ-$2.7019.85%
2021NZ-$2.2561.9%
2020NZ-$1.39-216.67%
2019NZ$1.19-210.77%
2018NZ-$1.0838.3%
2017NZ-$0.78-64.93%
2016NZ-$2.22-16.25%
2015NZ-$2.6528%
2014NZ-$2.07-3.85%
2013NZ-$2.15-31.58%
2012NZ-$3.15331.82%
2011NZ-$0.73-51.11%
2010NZ-$1.49-79.07%
2009NZ-$7.12-37.68%
2008NZ-$11.43-16.87%
2007NZ-$13.7538.33%
2006NZ-$9.94122.22%
2005NZ-$4.4742.11%
2004NZ-$3.15533.33%
2003NZ-$0.50-99.08%
2002NZ-$53.7725%
2001NZ-$43.0233.33%
2000NZ-$32.26-120%
1999NZ$161.31-400%
1998NZ-$53.77-81.48%
1997NZ-$290.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.29-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$13.36 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$3.96-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.15-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$4.77 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA